Skip to main content
Erschienen in:

12.05.2023 | Original Article

Circulatory levels of multiple microRNA associated with prediabetes

verfasst von: Pratibha Misra, Athira S. V., Palaniswamy R., Karthik K., Y. Vashum, Ruchira G., Sibin M. K.

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Prediabetes is an intermediate condition which transits to diabetes mellitus on later stage. Identifying a noninvasive marker may help in the early detection of this stage. Role of circulatory miRNAs as biomarker was explored in various disease conditions including prediabetes. Six potential circulatory miRNAs associated most studied in prediabetes were shortlisted and their diagnostic utility was evaluated in the present study.

Materials and methods

Fifty-seven subjects with prediabetes as per American Diabetes Association criteria and 57 normoglycemic healthy subjects were included in the present study. Expression levels of six miRNAs, miR-15a-5p, miR-23a-3p, miR-29a-3p, miR-30d-5p, miR-126-3p, and miR-192-5p in serum were quantified using real-time PCR. Association of their expression with biochemical parameters and diagnostic utility of miRNAs was assessed.

Results

The result confirm that the selected circulating serum miRNAs were over expressed in prediabetes compared to healthy controls and the KEGG pathway analysis for the same revealed 37 high risk pathways. Furthermore, study revealed that as a single marker miR-15a-5p, miR-126-3p and miR-192-5p had a sensitivity of 67.86, 58.93 and 71.43 at 60.71, 58.93 and 66.07, respectively.

Conclusion

Results of the present study concluded that miR-15a-5p, miR-126-3p, and miR-192-5p in serum might be used as reliable, minimally invasive diagnostic biomarker to discriminate prediabetes from healthy individuals in addition to existing biomarkers. Future studies with larger number of subjects are needed to establish clinical utility of this panel.
Literatur
1.
Zurück zum Zitat American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes care. 2019 1; 42(Supplement_1):S13-28. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes care. 2019 1; 42(Supplement_1):S13-28.
2.
Zurück zum Zitat Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96.CrossRefPubMed Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96.CrossRefPubMed
3.
Zurück zum Zitat Anjana RM, Shanthi Rani CS, Deepa M, Pradeepa R, Sudha V, Divya Nair H, Lakshmipriya N, Subhashini S, Binu VS, Unnikrishnan R, Mohan V. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care. 2015;38(8):1441–8.CrossRefPubMed Anjana RM, Shanthi Rani CS, Deepa M, Pradeepa R, Sudha V, Divya Nair H, Lakshmipriya N, Subhashini S, Binu VS, Unnikrishnan R, Mohan V. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care. 2015;38(8):1441–8.CrossRefPubMed
4.
Zurück zum Zitat Athira SV, Pratibha M, Kapil B, Sibin MK. Identification of circulatory miRNAs as candidate biomarkers in prediabetes-a systematic review and bioinformatics analysis. Gene Reports. 2020;1(21): 100954. Athira SV, Pratibha M, Kapil B, Sibin MK. Identification of circulatory miRNAs as candidate biomarkers in prediabetes-a systematic review and bioinformatics analysis. Gene Reports. 2020;1(21): 100954.
5.
Zurück zum Zitat Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;27(4):37. Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;27(4):37.
7.
Zurück zum Zitat Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272–84.CrossRefPubMedPubMedCentral Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272–84.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Flowers E, Gadgil M, Aouizerat BE, Kanaya AM. Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomarker Research. 2015;3(1):1–8.CrossRef Flowers E, Gadgil M, Aouizerat BE, Kanaya AM. Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomarker Research. 2015;3(1):1–8.CrossRef
9.
Zurück zum Zitat Ghaneh T, Zeinali F, Babini H, Astaraki S, Hassan-Zadeh V. An increase in the expression of circulating miR30d-5p and miR126-3p is associated with intermediate hyperglycaemia in Iranian population. Arch Physiol Biochem. 2020;26:1–8. Ghaneh T, Zeinali F, Babini H, Astaraki S, Hassan-Zadeh V. An increase in the expression of circulating miR30d-5p and miR126-3p is associated with intermediate hyperglycaemia in Iranian population. Arch Physiol Biochem. 2020;26:1–8.
10.
Zurück zum Zitat Hajjar A, Alagoz O. Personalized disease screening decisions considering a chronic condition. Management Science. 2022; 25. Hajjar A, Alagoz O. Personalized disease screening decisions considering a chronic condition. Management Science. 2022; 25.
11.
Zurück zum Zitat Liu XL, Pan Q, Cao HX, Xin FZ, Zhao ZH, Yang RX, Zeng J, Zhou H, Fan JG. Lipotoxic hepatocyte-derived exosomal microRNA 192–5p activates macrophages through rictor/Akt/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease. Hepatology. 2020;72(2):454–69.CrossRefPubMed Liu XL, Pan Q, Cao HX, Xin FZ, Zhao ZH, Yang RX, Zeng J, Zhou H, Fan JG. Lipotoxic hepatocyte-derived exosomal microRNA 192–5p activates macrophages through rictor/Akt/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease. Hepatology. 2020;72(2):454–69.CrossRefPubMed
12.
Zurück zum Zitat Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567–77.CrossRefPubMedPubMedCentral Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567–77.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Lopez YO, Garufi G, Seyhan AA. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol BioSyst. 2017;13(1):106–21.CrossRef Lopez YO, Garufi G, Seyhan AA. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol BioSyst. 2017;13(1):106–21.CrossRef
14.
Zurück zum Zitat Matsha TE, Kengne AP, Hector S, Mbu DL, Yako YY, Erasmus RT. MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus. Oncotarget. 2018;9(55):30485.CrossRefPubMedPubMedCentral Matsha TE, Kengne AP, Hector S, Mbu DL, Yako YY, Erasmus RT. MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus. Oncotarget. 2018;9(55):30485.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Nik Mohamed Kamal NN, Shahidan WN. Non-exosomal and exosomal circulatory microRNAs: Which are more valid as biomarkers? Frontiers in pharmacology. 2020:1500. Nik Mohamed Kamal NN, Shahidan WN. Non-exosomal and exosomal circulatory microRNAs: Which are more valid as biomarkers? Frontiers in pharmacology. 2020:1500.
16.
Zurück zum Zitat Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martinez C, Ricart W, Rieusset J, Rome S. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37(5):1375–83.CrossRefPubMed Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martinez C, Ricart W, Rieusset J, Rome S. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37(5):1375–83.CrossRefPubMed
17.
Zurück zum Zitat Párrizas M, Brugnara L, Esteban Y, González-Franquesa A, Canivell S, Murillo S, Gordillo-Bastidas E, Cussó R, Cadefau JA, García-Roves PM, Servitja JM. Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. J Clin Endocrinol Metab. 2015;100(3):E407–15.CrossRefPubMed Párrizas M, Brugnara L, Esteban Y, González-Franquesa A, Canivell S, Murillo S, Gordillo-Bastidas E, Cussó R, Cadefau JA, García-Roves PM, Servitja JM. Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. J Clin Endocrinol Metab. 2015;100(3):E407–15.CrossRefPubMed
18.
Zurück zum Zitat Pirola CJ, Gianotti TF, Castaño GO, Mallardi P, San Martino J, Ledesma MM, Flichman D, Mirshahi F, Sanyal AJ, Sookoian S. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2015;64(5):800–12.CrossRefPubMed Pirola CJ, Gianotti TF, Castaño GO, Mallardi P, San Martino J, Ledesma MM, Flichman D, Mirshahi F, Sanyal AJ, Sookoian S. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2015;64(5):800–12.CrossRefPubMed
19.
Zurück zum Zitat Rehman K, Akash MS, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews™ in Eukaryotic Gene Expression. 2017; 27(3). Rehman K, Akash MS, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews™ in Eukaryotic Gene Expression. 2017; 27(3).
21.
Zurück zum Zitat Salloum-Asfar S, Satheesh NJ, Abdulla SA. Circulating miRNAs, small but promising biomarkers for autism spectrum disorder. Front Mol Neurosci. 2019;11(12):253.CrossRef Salloum-Asfar S, Satheesh NJ, Abdulla SA. Circulating miRNAs, small but promising biomarkers for autism spectrum disorder. Front Mol Neurosci. 2019;11(12):253.CrossRef
22.
Zurück zum Zitat Sattar N, Gill JM. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol. 2015;3(12):1004–16.CrossRefPubMed Sattar N, Gill JM. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol. 2015;3(12):1004–16.CrossRefPubMed
23.
Zurück zum Zitat Seyhan AA, Nunez Lopez YO, Xie H, Yi F, Mathews C, Pasarica M, Pratley RE. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;6(1):1–5.CrossRef Seyhan AA, Nunez Lopez YO, Xie H, Yi F, Mathews C, Pasarica M, Pratley RE. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;6(1):1–5.CrossRef
24.
Zurück zum Zitat Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res. 2012;93(4):583–93.CrossRefPubMed Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res. 2012;93(4):583–93.CrossRefPubMed
25.
Zurück zum Zitat Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011;91(1):94–100.CrossRefPubMed Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011;91(1):94–100.CrossRefPubMed
26.
Zurück zum Zitat Van de Bunt M, Gaulton KJ, Parts L, Moran I, Johnson PR, Lindgren CM, Ferrer J, Gloyn AL, McCarthy MI. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE. 2013;8(1): e55272.CrossRefPubMedPubMedCentral Van de Bunt M, Gaulton KJ, Parts L, Moran I, Johnson PR, Lindgren CM, Ferrer J, Gloyn AL, McCarthy MI. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE. 2013;8(1): e55272.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Vasu S, Kumano K, Darden CM, Rahman I, Lawrence MC, Naziruddin B. MicroRNA signatures as future biomarkers for diagnosis of diabetes states. Cells. 2019;8(12):1533.CrossRefPubMedPubMedCentral Vasu S, Kumano K, Darden CM, Rahman I, Lawrence MC, Naziruddin B. MicroRNA signatures as future biomarkers for diagnosis of diabetes states. Cells. 2019;8(12):1533.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wang X, Sundquist J, Zöller B, Memon AA, Palmér K, Sundquist K, Bennet L. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS ONE. 2014;9(1): e86792.CrossRefPubMedPubMedCentral Wang X, Sundquist J, Zöller B, Memon AA, Palmér K, Sundquist K, Bennet L. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS ONE. 2014;9(1): e86792.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Weale CJ, Matshazi DM, Davids SF, Raghubeer S, Erasmus RT, Kengne AP, Davison GM, Matsha TE. MicroRNAs-1299,-126-3p and-30e-3p as potential diagnostic biomarkers for prediabetes. Diagnostics. 2021;11(6):949.CrossRefPubMedPubMedCentral Weale CJ, Matshazi DM, Davids SF, Raghubeer S, Erasmus RT, Kengne AP, Davison GM, Matsha TE. MicroRNAs-1299,-126-3p and-30e-3p as potential diagnostic biomarkers for prediabetes. Diagnostics. 2021;11(6):949.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Yang Z, Chen H, Si H, Li X, Ding X, Sheng Q, Chen P, Zhang H. Serum miR-23a, a potential biomarker for diagnosis of prediabetes and type 2 diabetes. Acta Diabetol. 2014;51(5):823–31.CrossRefPubMed Yang Z, Chen H, Si H, Li X, Ding X, Sheng Q, Chen P, Zhang H. Serum miR-23a, a potential biomarker for diagnosis of prediabetes and type 2 diabetes. Acta Diabetol. 2014;51(5):823–31.CrossRefPubMed
31.
Zurück zum Zitat Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810–7.CrossRefPubMed Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810–7.CrossRefPubMed
32.
Zurück zum Zitat Zeinali F, Aghaei Zarch SM, Jahan-Mihan A, Kalantar SM, Vahidi Mehrjardi MY, Fallahzadeh H, Hosseinzadeh M, Rahmanian M, Mozaffari-Khosravi H. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with prediabetes and type 2 diabetes mellitus: A case control study. PLoS ONE. 2021;16(6): e0251697.CrossRefPubMedPubMedCentral Zeinali F, Aghaei Zarch SM, Jahan-Mihan A, Kalantar SM, Vahidi Mehrjardi MY, Fallahzadeh H, Hosseinzadeh M, Rahmanian M, Mozaffari-Khosravi H. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with prediabetes and type 2 diabetes mellitus: A case control study. PLoS ONE. 2021;16(6): e0251697.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRefPubMed Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRefPubMed
34.
Zurück zum Zitat Zhu H, Leung SW. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia. 2015;58(5):900–11.CrossRefPubMed Zhu H, Leung SW. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia. 2015;58(5):900–11.CrossRefPubMed
Metadaten
Titel
Circulatory levels of multiple microRNA associated with prediabetes
verfasst von
Pratibha Misra
Athira S. V.
Palaniswamy R.
Karthik K.
Y. Vashum
Ruchira G.
Sibin M. K.
Publikationsdatum
12.05.2023
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 6/2023
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-023-01208-1